Single Peptides · Exact presentation
Gonadorelin · 2 mg Vial
Gonadorelin · 2 mg Vial is an exact single peptide or compound entry. This strength is kept separate because concentration and calculations depend on vial amount.
Educational research information for this exact variation. It is not medical advice, a prescription, or proof of regulatory approval.
Dosing & Reconstitution Guide
For a 2 mg presentation, the reference concentration of 1 mg/mL mathematically corresponds to 2 mL final volume. This is concentration math, not a universal preparation instruction; the lot CoA and documentation control. 1 mg/mL. On a U-100 syringe, 1 unit equals 0.01 mL; the amount per unit would be 0.01 mg at this concentration.
Standard / Maintenance Approach (2 mL = 1 mg/mL)
The source chart summarizes “50 mcg–150 mcg” at “Weekly” frequency as educational information. PeptidosRD does not convert it into a clinical recommendation; any protocol must be checked against primary studies, applicable labeling, and qualified oversight.
Standard / Maintenance Approach (2 mL = 1 mg/mL)
| Week/Phase | Dose per Injection (mcg) | Units (mL) |
|---|---|---|
| Weeks 1–2 (Initiation) | 50 mcg | 5 units (0.05 mL) |
| Weeks 3–4 (Titration) | 100 mcg | 10 units (0.10 mL) |
| Weeks 5–8 (Maintenance) | 100–150 mcg | 10–15 units (0.10–0.15 mL) |
Reconstitution Steps
For a 2 mg presentation, the reference concentration of 1 mg/mL mathematically corresponds to 2 mL final volume. This is concentration math, not a universal preparation instruction; the lot CoA and documentation control. 1 mg/mL. On a U-100 syringe, 1 unit equals 0.01 mL; the amount per unit would be 0.01 mg at this concentration.
Advanced / Post‑Cycle Support Approach
The source chart summarizes “50 mcg–150 mcg” at “Weekly” frequency as educational information. PeptidosRD does not convert it into a clinical recommendation; any protocol must be checked against primary studies, applicable labeling, and qualified oversight.
Advanced / Post‑Cycle Support Approach
| Week/Phase | Dose per Injection (mcg) | Units (mL) |
|---|---|---|
| Days 1–7 (Burst) | 200 mcg | 20 units (0.20 mL) |
| Days 8–14 (Taper) | 100 mcg | 10 units (0.10 mL) |
| Week 3+ (Optional Maintenance) | 100 mcg 2–3×/wk | 10 units (0.10 mL) |
Storage Instructions
Proper storage preserves peptide quality.
Lyophilized: Store at −20 °C (−4 °F) in dry, dark conditions; stable for 1+ year.[5]
Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); use within 3–4 weeks and avoid freeze–thaw.[6]
Allow vials to reach room temperature before opening to reduce condensation uptake.
How This Works
It is studied in cellular bioenergetics, mitochondrial function, substrate metabolism, or stress signaling. The specific molecular target depends on the compound.
Potential Benefits & Side Effects
A biochemical effect should not be extrapolated to a clinical outcome. Formulation, concentration, and studied population are decisive.
Source trail
Scientific references and source discovery
- PeptideDosages — exact Gonadorelin · 2 mg Vial entrysecondary-structure
- PubMed — literature search for Gonadorelinprimary-discovery
- ClinicalTrials.gov — study search for Gonadorelintrial-registry
- View Sourcesource-reference
- View Sourcesource-reference
- View Sourcesource-reference
- View Sourcesource-reference
- View Sourcesource-reference
- View Sourcesource-reference
- View Sourcesource-reference
- View Sourcesource-reference